Gregory I. Frost

2013

In 2013, Gregory I. Frost earned a total compensation of $1.5M as Former President and Chief Executive Officer at Halozyme Therapeutics, a 34% decrease compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$544,583
Option Awards$259,721
Salary$453,819
Stock Awards$255,450
Other$2,993
Total$1,516,566

Frost received $544.6K in non-equity incentive plan, accounting for 36% of the total pay in 2013.

Frost also received $259.7K in option awards, $453.8K in salary, $255.5K in stock awards and $3K in other compensation.

Rankings

In 2013, Gregory I. Frost's compensation ranked 4,884th out of 12,286 executives tracked by ExecPay. In other words, Frost earned more than 60.2% of executives.

ClassificationRankingPercentile
All
4,884
out of 12,286
60th
Division
Manufacturing
1,687
out of 4,612
63rd
Major group
Chemicals And Allied Products
485
out of 1,466
67th
Industry group
Drugs
342
out of 1,160
71st
Industry
Biological Products, Except Diagnostic Substances
53
out of 200
74th
Source: SEC filing on April 3, 2015.

Frost's colleagues

We found five more compensation records of executives who worked with Gregory I. Frost at Halozyme Therapeutics in 2013.

2013

David Ramsay

Halozyme Therapeutics

Chief Financial Officer

2013

James Shaffer

Halozyme Therapeutics

Former Vice President and Chief Commercial Officer

2013

Jean Liu

Halozyme Therapeutics

General Counsel

2013

H Shepard

Halozyme Therapeutics

Chief Scientific Officer

2013

Kurt Gustafson

Halozyme Therapeutics

Chief Financial Officer

You may also like